Ivabradine Patent Expiration
Ivabradine is Used for treating heart failure in humans. It was first introduced by Amgen Inc
Ivabradine Patents
Given below is the list of patents protecting Ivabradine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Corlanor | US7361649 | β-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Feb 22, 2026 | Amgen Inc |
| Corlanor | US7361650 | γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Feb 22, 2026 | Amgen Inc |
| Corlanor | US7867996 | γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Dec 12, 2026 | Amgen Inc |
| Corlanor | US7879842 | Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Feb 22, 2026 | Amgen Inc |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳